102 related articles for article (PubMed ID: 22268002)
1. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.
Pai R; French D; Ma N; Hotzel K; Plise E; Salphati L; Setchell KD; Ware J; Lauriault V; Schutt L; Hartley D; Dambach D
Toxicol Sci; 2012 Apr; 126(2):446-56. PubMed ID: 22268002
[TBL] [Abstract][Full Text] [Related]
2. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.
Pan Q; Zhang X; Zhang L; Cheng Y; Zhao N; Li F; Zhou X; Chen S; Li J; Xu S; Huang D; Chen Y; Li L; Wang H; Chen W; Cai SY; Boyer JL; Chai J
Gastroenterology; 2018 Nov; 155(5):1578-1592.e16. PubMed ID: 30063921
[TBL] [Abstract][Full Text] [Related]
3. An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis.
Wang Y; Gunewardena S; Li F; Matye DJ; Chen C; Chao X; Jung T; Zhang Y; Czerwiński M; Ni HM; Ding WX; Li T
Nat Commun; 2020 Jul; 11(1):3612. PubMed ID: 32681035
[TBL] [Abstract][Full Text] [Related]
4. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.
Herrera J; Amigo L; Husche C; Benítez C; Zanlungo S; Lütjohann D; Miquel JF; Nervi F
Lipids Health Dis; 2009 Dec; 8():53. PubMed ID: 19995447
[TBL] [Abstract][Full Text] [Related]
5. Mice with chimeric livers are an improved model for human lipoprotein metabolism.
Ellis EC; Naugler WE; Parini P; Mörk LM; Jorns C; Zemack H; Sandblom AL; Björkhem I; Ericzon BG; Wilson EM; Strom SC; Grompe M
PLoS One; 2013; 8(11):e78550. PubMed ID: 24223822
[TBL] [Abstract][Full Text] [Related]
6. Colchicine disrupts bile acid metabolic homeostasis by affecting the enterohepatic circulation in mice.
Shi Y; Wei L; Jin F; Wang J; Cao H; Yang Y; Gao L
J Appl Toxicol; 2024 Jun; 44(6):863-873. PubMed ID: 38311468
[TBL] [Abstract][Full Text] [Related]
7. Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls.
Nerild HH; Gilliam-Vigh H; Ellegaard AM; Forman JL; Vilsbøll T; Sonne DP; Brønden A; Knop FK
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38636096
[TBL] [Abstract][Full Text] [Related]
8. Increased Circulating Cortisol After Vaginal Birth Is Associated With Increased FGF19 Secretion in Neonatal Pigs.
Vonderohe C; Guthrie G; Stoll B; Hebib VM; Dawson H; Burrin D
Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36367732
[TBL] [Abstract][Full Text] [Related]
9. Ileal mucosal bile acid absorption is increased in Cftr knockout mice.
Stelzner M; Somasundaram S; Lee SP; Kuver R
BMC Gastroenterol; 2001; 1():10. PubMed ID: 11696242
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 19 secretion and function in perinatal development.
Vonderohe C; Guthrie G; Burrin DG
Am J Physiol Gastrointest Liver Physiol; 2023 Mar; 324(3):G190-G195. PubMed ID: 36648144
[TBL] [Abstract][Full Text] [Related]
11. Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes.
Weaver MJ; McHenry SA; Sayuk GS; Gyawali CP; Davidson NO
Hepatol Commun; 2020 Apr; 4(4):493-503. PubMed ID: 32258945
[TBL] [Abstract][Full Text] [Related]
12. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice.
Cheng K; Metry M; Felton J; Shang AC; Drachenberg CB; Xu S; Zhan M; Schumacher J; Guo GL; Polli JE; Raufman JP
Oncotarget; 2018 May; 9(39):25572-25585. PubMed ID: 29876009
[TBL] [Abstract][Full Text] [Related]
13. Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism.
Briggs K; Tomar V; Ollberding N; Haberman Y; Bourgonje AR; Hu S; Chaaban L; Sunuwar L; Weersma RK; Denson LA; Melia JMP
Inflamm Bowel Dis; 2024 Jan; ():. PubMed ID: 38289995
[TBL] [Abstract][Full Text] [Related]
14. Effects of FGF19 Analogue Aldafermin in Patients With Bile Acid Diarrhea: A Randomized, Placebo-Control Trial.
BouSaba J; Torres M; Dilmaghani S; Harmsen WS; Ling L; Camilleri M
Gastroenterology; 2023 Aug; 165(2):499-501.e4. PubMed ID: 37084852
[No Abstract] [Full Text] [Related]
15. Positive phase III trials for ileal bile acid transporter inhibitors.
Ray K
Nat Rev Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38783126
[No Abstract] [Full Text] [Related]
16. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.
Mellor HR
Liver Int; 2014 Jul; 34(6):e1-9. PubMed ID: 24393342
[TBL] [Abstract][Full Text] [Related]
17. First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Hagel M; Miduturu C; Sheets M; Rubin N; Weng W; Stransky N; Bifulco N; Kim JL; Hodous B; Brooijmans N; Shutes A; Winter C; Lengauer C; Kohl NE; Guzi T
Cancer Discov; 2015 Apr; 5(4):424-37. PubMed ID: 25776529
[TBL] [Abstract][Full Text] [Related]
18. Looking into the "Garden of the Hesperides": new drugs for hepatocellular carcinoma.
Castañón Alvarez E; Giallombardo M; Gil-Bazo I; Papadimitriou K; Pauwels P; Peeters M; Rolfo C
Minerva Chir; 2015 Apr; 70(2):119-29. PubMed ID: 25614940
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics.
Parish A; Schwaederle M; Daniels G; Piccioni D; Fanta P; Schwab R; Shimabukuro K; Parker BA; Helsten T; Kurzrock R
Cell Cycle; 2015; 14(13):2121-8. PubMed ID: 25950492
[TBL] [Abstract][Full Text] [Related]
20. Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice.
Yu XX; Watts LM; Manchem VP; Chakravarty K; Monia BP; McCaleb ML; Bhanot S
PLoS One; 2013; 8(7):e66923. PubMed ID: 23922646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
